Abstract:Introduction: Overcoming the challenge of low solubility in pharmaceutical research is critical, particularly for poorly soluble drugs. This study focuses on the development and characterization of a self-nano emulsifying drug delivery system (SNEDDS) based on alginate, intending to enhance the solubility of fenofibrate, a BCS class II drug known for its low aqueous solubility. Methods and materials: The process of formulation optimization involved the preparation of SNEDDS formulations using varying proportions of oleic acid (as the oily phase), Tween 80 (as the surfactant), and PEG 400 (as the cosurfactant). A ternary graph depicting oil-water and surfactant/cosurfactant combinations was constructed to analyze different formulations. Dynamic light diffraction determined the formulations' particle size and polydispersity index. Based on these results, four SNEDDS formulations were selected for further investigation. Different ratios of alginate, an adhesive mucus polymer, were incorporated into these formulations. The particle size, polydispersity index, and light transmission were measured for each formulation with varying alginate ratios. Optimal alginate ratios were selected based on these measurements. The solubility of fenofibrate was also assessed in a solution without polymer. Rheology tests were performed on formulations in the absence and presence of polymer using the selected alginate ratios. Validation studies were performed according to the US Pharmacopoeia for fenofibrate, with accuracy determined by measuring the absorbance of standard samples at different concentrations and precision calculated by analyzing the mean value and standard deviation. The physical stability of the selected formulations was evaluated over three months at room temperature. The fenofibrate release pattern from the SNEDDS was also conducted using the dialysis method with a cellulose membrane dialysis bag in the simulated gastric and intestinal environments without GI enzymes. Results: The results demonstrated that the optimized SNEDDS formulations, comprising appropriate amounts of oleic acid, Tween 80/PEG 400 surfactant mixture, and alginate polymer, exhibited desirable particle sizes ranging from 149.9 to 210.6 nm and polydispersity index values between 0.314 and 0.451. Rheological analysis indicated increased viscosity with the addition of alginate. In vitro drug release studies revealed a sustained release pattern for polymer-containing formulations compared to polymer-free formulations, with 102 mg/g solution rates and 124 mg/g for the two final formulations. Moreover, the nanosystem formulation significantly improved the dissolution rate of fenofibrate compared to the free drug form in both simulated gastric and intestinal environments. Conclusion and discussion: The developed alginate-based self-nano emulsifying system shows promise in enhancing fenofibrate's solubility and dissolution rate. This research contributes to exploring novel strategies for improving the bioavailability of poorly soluble drugs.

Optimization and Characterization of Sodium Alginate Beads Providing Extended Release for Antidiabetic Drugs

Formulation and Evaluation of Insulin-Loaded Sodium-Alginate Microparticles for Oral Administration

Evaluation of sodium alginate as drug release modifier in matrix tablets

A facile fabrication of core–shell sodium alginate/gelatin beads for drug delivery systems

Preparation and Characterization of Sodium Alginate‐Based Hydrogel for Delivery of Hydrophilic Drug Metformin Hydrochloride

Formulation, Statistical Optimization, and In Vivo Pharmacodynamics of Cydonia oblonga Mucilage/Alginate Mucoadhesive Microspheres for the Delivery of Metformin HCl

Development and Characterization of an Alginate-Based Self-Nanoemulsifying System for Enhanced Solubility of Fenofibrate

Preparation and evaluation of chitosan-alginate/carrageenan hydrogel for oral drug delivery in the treatment of diabetes

Fabrication of Ca-alginate microspheres by diffusion-induced gelation in double emulsion droplets for oral insulin

Development of Alginate- Neusilin US2 (Magnesium alumino-metasilicate) micro-composite hydrogel beads for oral sustained release of cilnidipine: a statistical optimization

Formulation, design and optimization of antidiabetic drug loaded microspheres

Designing Advanced Drug Delivery Systems: Core-Shell Alginate Particles through Electro-Fluid Dynamic Atomization

Development of novel gastroretentive floating particulate drug delivery system of gliclazide

A Novel Controlled Drug Delivery System Based on Alginate Hydrogel/chitosan Micelle Composites.

Experimental and Theoretical Design on the Development of Matrix Tablets with Multiple Drug Loadings Aimed at Optimizing Antidiabetic Medication

Study On Poly(D,L-Lactic) Microspheres Embedded In Calcium Alginate Hydrogel Beads As Dual Drug Delivery Systems

Development and characterization of new enzymatic modified hybrid calcium carbonate microparticles to obtain nano-architectured surfaces for enhanced drug loading

Sodium alginate and carbopol microcapsules: preparation, polyphenol encapsulation and release efficiency

Preparation and Characterization of Sodium Alginate-reduced Graphene Oxide Microbeads for Co-Delivery of Doxorubicin and 5-Fluorouracil

Effect of Formulation Parameters and Physiological Environment on Amlodipine Release Kinetics Encapsulated in Biodegradable Polymers and Optimized by Design Methodology

One-step fabrication of core-shell structured alginate-PLGA/PLLA microparticles as a novel drug delivery system for water soluble drugs.